Table 1 Demographic and clinical characteristics of CD patients and HCs.
CD (n = 52) | HCs (n = 36) | P value | ||
|---|---|---|---|---|
Gender (male/female), n | 37/15 | 24/12 | 0.65 | |
Age (years), mean + SD | 30.85 ± 7.60 | 30.33 ± 5.75 | 0.73 | |
Height (cm), mean + SD | 170.15 ± 6.96 | 169.47 ± 7.17 | 0.66 | |
Weight (kg), mean + SD | 56.85 ± 9.27 | 59.58 ± 6.49 | 0.13 | |
Disease duration (years), mean + SD | 6.30 ± 4.07 | — | — | |
CDAI, mean + SD | 71.22 ± 42.03 | — | — | |
IBDQ, mean + SD | 174.23 ± 26.98 | — | — | |
Platelet▽, mean + SD | 218.79 ± 44.72 | — | — | |
Erythrocyte sedimentation rate△, mean + SD | 11.46 ± 5.53 | — | — | |
C, reactive protein▼, mean + SD | 5.01 ± 5.86 | — | — | |
CDEIS, mean + SD | 1.05 ± 0.69 | — | — | |
Montreal classification | ||||
Age at diagnosis | A1 | 4 | — | — |
A2 | 46 | — | — | |
A3 | 2 | — | — | |
Location | L1 | 10 | — | — |
L2 | 12 | — | — | |
L3 | 30 | — | — | |
L4 | 0 | — | — | |
Behavior | B1 | 17 | — | — |
B2 | 3 | — | — | |
B3 | 14 | — | — | |
B1P | 5 | — | — | |
B2P | 1 | — | — | |
B3P | 12 | — | — | |
Concomitant medication | ||||
Mesalazine | 37 | — | — | |
Azathioprine | 12 | — | — | |
